Addus HomeCare Corporation (FRA:A41)
Germany · Delayed Price · Currency is EUR | Market Cap | 1.89B +3.3% |
| Revenue (ttm) | 1.29B +15.9% |
| Net Income | 92.17M +26.9% |
| EPS | 5.00 +26.2% |
| Shares Out | n/a |
| PE Ratio | 20.55 |
| Forward PE | 16.54 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 101.00 |
| Previous Close | 101.00 |
| Day's Range | 101.00 - 101.00 |
| 52-Week Range | 74.50 - 104.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 3, 2026 |
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal ... [Read more]
Financial Performance
In 2025, Addus HomeCare's revenue was $1.42 billion, an increase of 23.21% compared to the previous year's $1.15 billion. Earnings were $95.91 million, an increase of 30.32%.
Financial numbers in USD Financial StatementsNews
Addus HomeCare management to meet virtually with William Blair
Virtual Meeting to be held on August 18 hosted by William Blair.
Addus HomeCare announces departure of Chief Operating Officer Dixon
Addus HomeCare (ADUS) announced that Heather Dixon, President and Chief Operating Officer, is no longer with the Company. Brad Bickham, former President and Chief Operating Officer at Addus, has agree...
Addus HomeCare Announces Departure of Heather Dixon and Return of Brad Bickham as Chief Operating Officer on an Interim Basis
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS) (the “Company”), a provider of home care services, announced today that Heather Dixon, President and Chief Operating Officer, ...
Addus HomeCare price target raised to $136 from $130 at Stephens
Stephens raised the firm’s price target on Addus HomeCare (ADUS) to $136 from $130 and keeps an Overweight rating on the shares. The firm adjusted estimates following the company’s Q2…
Addus HomeCare price target raised to $134 from $130 at RBC Capital
RBC Capital raised the firm’s price target on Addus HomeCare (ADUS) to $134 from $130 and keeps an Outperform rating on the shares. Addus delivered a solid Q2 driven by…
Addus HomeCare Earnings Call Transcript: Q2 2026
Revenue grew 8% year-over-year to $377.4M, with adjusted EPS up 16% and adjusted EBITDA up 12%. Personal care and hospice segments drove growth, while home health showed sequential improvement. Strong cash flow and reduced debt support ongoing acquisitions and expansion.
Addus HomeCare Earnings release: Q2 2026
Addus HomeCare released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Addus HomeCare Quarterly report: Q2 2026
Addus HomeCare has published its Q2 2026 quarterly earnings report on August 4, 2026.
Addus HomeCare reports Q2 adjusted EPS $1.73, consensus $1.70
Reports Q2 revenue $377.4M, consensus $376.22M. Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, “We are extremely pleased with the strong financial and operational...
Addus HomeCare Announces Second Quarter 2026 Financial Results
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the second quarter and six months ended June 30, ...
Addus HomeCare Announces Second Quarter 2026 Earnings Release and Conference Call
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the second quarter ended June 30, 2026, o...
Addus HomeCare price target raised to $96 from $92 at Barclays
Barclays analyst Andrew Mok raised the firm’s price target on Addus HomeCare (ADUS) to $96 from $92 and keeps an Underweight rating on the shares. The firm adjusted targets among…
Addus HomeCare Transcript: AGM 2026
The meeting confirmed a quorum and proceeded with the election of two directors, ratification of the auditor, and advisory approval of executive compensation, all of which passed by majority or plurality vote. Shareholders could submit questions online.
Addus HomeCare Transcript: RBC Capital Markets Global Healthcare Conference 2026
Regulatory changes have minimal impact on PCS growth and acquisition plans, while compliance investments strengthen payer relationships. Operational momentum continues in key states, with technology and Bridge Programs supporting census and admissions growth. M&A activity is robust, and financial outlook remains positive.
Addus HomeCare price target lowered to $92 from $102 at Barclays
Barclays lowered the firm’s price target on Addus HomeCare (ADUS) to $92 from $102 and keeps an Underweight rating on the shares. The Centers for Medicare and Medicaid Services imposed…
Addus HomeCare Transcript: Bank of America Global Healthcare Conference 2026
Sequential census and hours growth continued across major markets, aided by technology adoption and operational efficiencies. Balanced growth between rate and volume is being achieved, with recent acquisitions expanding scale and payer relationships. Regulatory and reimbursement outlooks remain stable, supporting ongoing M&A and segment growth strategies.
Addus HomeCare price target lowered to $142 from $150 at Citizens
Citizens lowered the firm’s price target on Addus HomeCare (ADUS) to $142 from $150 and keeps an Outperform rating on the shares. The firm’s outlook remains constructive, with expectations for…
Addus HomeCare to Participate in Upcoming Investor Conferences in May
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced its participation at the following investor conferences in May: BofA Securi...
Addus HomeCare price target lowered to $140 from $147 at BofA
BofA lowered the firm’s price target on Addus HomeCare (ADUS) to $140 from $147 and keeps a Buy rating on the shares. Following the company’s Q1 report, the firm maintains…
Addus HomeCare Earnings Call Transcript: Q1 2026
Revenue grew 7.7% to $363.6M in Q1 2026, with adjusted EPS up 14.1% and strong cash flow supporting debt reduction and M&A. Personal care and hospice segments drove growth, aided by rate increases and operational improvements.
Addus HomeCare Earnings release: Q1 2026
Addus HomeCare released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.
Addus HomeCare Quarterly report: Q1 2026
Addus HomeCare has published its Q1 2026 quarterly earnings report on May 5, 2026.
Addus HomeCare Slides: Q1 2026
Addus HomeCare has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 5, 2026.
Addus HomeCare reports Q1 adjusted EPS $1.62, consensus $1.54
Reports Q1 revenue $363.6M, consensus $366.34M. Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, “Addus had a solid start to 2026, delivering an improved year-over-...
Addus HomeCare sees ‘significant opportunities’ in 2026 for organic growth
“We are pleased with the favorable trends in our business and believe we have significant opportunities in 2026 for continued organic growth and for deriving additional value from acquired operations.